hrcak mascot   Srce   HID

Stručni rad

PROPHYLAXIS OF MIGRAINE – A REVIEW OF LITERATURE

ANA ĆURKOVIĆ KATIĆ ; Split University Hospital Centre, Split, Croatia
MARIO MIHALJ ; Split University Hospital Centre and University of Split, School of Medicine, Department of Neurology, Split, Croatia
ANA REPIĆ BULIČIĆ ; Split University Hospital Centre, Split, Croatia
MARTINA VIDOVIĆ ; Split University Hospital Centre, Split, Croatia
MARINA TITLIĆ ; Split University Hospital Centre and University of Split, School of Medicine, Department of Neurology, Split, Croatia

Puni tekst: hrvatski, pdf (104 KB) str. 83-88 preuzimanja: 75* citiraj
APA 6th Edition
ĆURKOVIĆ KATIĆ, A., MIHALJ, M., REPIĆ BULIČIĆ, A., VIDOVIĆ, M. i TITLIĆ, M. (2020). PROFILAKSA MIGRENE – PRIKAZ LITERATURE. Acta medica Croatica, 74 (1), 83-88. Preuzeto s https://hrcak.srce.hr/237934
MLA 8th Edition
ĆURKOVIĆ KATIĆ, ANA, et al. "PROFILAKSA MIGRENE – PRIKAZ LITERATURE." Acta medica Croatica, vol. 74, br. 1, 2020, str. 83-88. https://hrcak.srce.hr/237934. Citirano 29.11.2020.
Chicago 17th Edition
ĆURKOVIĆ KATIĆ, ANA, MARIO MIHALJ, ANA REPIĆ BULIČIĆ, MARTINA VIDOVIĆ i MARINA TITLIĆ. "PROFILAKSA MIGRENE – PRIKAZ LITERATURE." Acta medica Croatica 74, br. 1 (2020): 83-88. https://hrcak.srce.hr/237934
Harvard
ĆURKOVIĆ KATIĆ, A., et al. (2020). 'PROFILAKSA MIGRENE – PRIKAZ LITERATURE', Acta medica Croatica, 74(1), str. 83-88. Preuzeto s: https://hrcak.srce.hr/237934 (Datum pristupa: 29.11.2020.)
Vancouver
ĆURKOVIĆ KATIĆ A, MIHALJ M, REPIĆ BULIČIĆ A, VIDOVIĆ M, TITLIĆ M. PROFILAKSA MIGRENE – PRIKAZ LITERATURE. Acta medica Croatica [Internet]. 2020 [pristupljeno 29.11.2020.];74(1):83-88. Dostupno na: https://hrcak.srce.hr/237934
IEEE
A. ĆURKOVIĆ KATIĆ, M. MIHALJ, A. REPIĆ BULIČIĆ, M. VIDOVIĆ i M. TITLIĆ, "PROFILAKSA MIGRENE – PRIKAZ LITERATURE", Acta medica Croatica, vol.74, br. 1, str. 83-88, 2020. [Online]. Dostupno na: https://hrcak.srce.hr/237934. [Citirano: 29.11.2020.]

Sažetak
This literature review is aimed at assessing the possibilities of migraine prophylaxis. The International Headache Society (IHS) recommends performing migraine prophylaxis in patients suffering ≥4 migraine headaches per month, either episodic or chronic. The treatment is deemed successful when the migraine attacks are decreased by ≥50%. Effi ciency has been demonstrated for β-blockers, calcium antagonists, antiepileptics such as topiramate and valproate, as well as gabapentin, pregabalin, fl unarizine and antidepressants. The effi ciency of levetiracetam, cervical myofascial anesthesia, skin electrostimulation and muscular stimulation is still being tested. The effects of botulinum toxin are dubious. There is ongoing research of the possibility of using histamines, closing foramen ovale, acupuncture, supraorbital and vagal nerve stimulation and transcranial magnetic stimulation. Effects of catecholamine, melatonin, contraceptives, ribofl avin, dextromethorphan and melatonin in persisting migraine headaches are being researched as well. Required is an appropriate assessment of the possible effects of probiotics, coenzyme q10 and magnesium in migraine prophylaxis. Clinical researches have shown the use of human monoclonal antibodies erenumab, fremanezumab and galcanezumab to demonstrate a statistically signifi cant effi ciency (≥50%) in migraine prophylaxis, yet requiring further confi rmation in clinical practice.

Ključne riječi
prophylaxis; migraine; efficiency

Hrčak ID: 237934

URI
https://hrcak.srce.hr/237934

[hrvatski]

Posjeta: 176 *